5071. Zytiga-H-C-2321-PSUV-0019 5072. Lemtrada-H-C-PSUSA-00010055-201703 5073. Exviera-H-C-3837-A20-0017 5074. Desloratadine Teva-H-C-PSUSA-00000962-201607 5075. EndolucinBeta-PSUSA-00010391-201612 5076. Eucreas-H-C-PSUSA-00003113-201502 5077. Neuraceq-H-C-PSUSA-00010094-201602 5078. Ofev-H-C-PSUSA-00010319-201604 5079. Xtandi-H-C-PSUSA-00010095-201408 5080. Trulicity-H-C-PSUSA-00010311-201709 5081. Veklury-H-C-PSUSA-00010840-202111: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 5082. Bonviva-H-C-PSUSA-00001702-202106 5083. Vaxzevria (previously COVID-19 Vaccine AstraZeneca)-H-C-PSUSA-00010912-202112 5084. Spikevax (previously COVID-19 Vaccine Moderna)-H-C-PSUSA-00010897-202112: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 5085. MabThera-H-C-PSUSA-00002652-202111 5086. Genvoya-H-C-PSUSA-00010449-202111 5087. Truxima : EPAR-H-C-PSUSA-00002652-202111 - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s) 5088. Myozyme-H-C-PSUSA-00000086-02109 5089. Suliqua-H-C-PSUSA-00010577-202111 5090. Vemlidy-H-C-PSUSA-00010575-202111 5091. Desloratadine Teva-H-C-PSUSA-00000962-202107 5092. Xalkori-PSUSA-00010042-202108 5093. Keytruda-H-C-PSUSA-00010403-202109 5094. Mysimba-H-C-PSUSA-00010366-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 5095. Fycompa-H-C-PSUSA-00009255-202107: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 5096. Viekirax-H-C-PSUV/SA/Art 20/Art 107i/Art 3 : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 5097. Vosevi-H-C-PSUV/SA/Art 20/Art 107i/Art 31 5098. Azopt-H-C-PSUSA-00000432-202108 5099. Emgality-H-C-PSUSA-00010733-202109 5100. Mayzent-PSUSA-00010818-202109: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation